I'm a biotech and AI analyst with a PhD in Physical Chemistry and over a decade tracking the intersection of technology and life sciences. I co-founded BiopharmaTrend.com, one of the earliest platforms covering AI in drug discovery, and have published analytical work cited by institutional and academic audiences worldwide. I write about the forces reshaping how science, technology, and capital interact — from the lab to the boardroom to the geopolitical stage.